Expanded phenotypic and hematologic abnormalities beyond bone marrow failure in MECOM ‐associated syndromes
American Journal of Medical Genetics Part A · 2023
DOI: 10.1002/ajmg.a.63208 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, 2023. Verfasst von Michell M Lozano Chinga und 11 weiteren Autor:innen. Beteiligte Einrichtung: Primary Children's Hospital, University of Utah, Salt Lake City, Utah, USA. Hauptthemen laut MEDLINE: Bone Marrow Diseases, Pancytopenia, Hematologic Diseases. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
The MECOM gene encodes multiple protein isoforms that are essential for hematopoietic stem cell self‐renewal and maintenance. Germline MECOM variants have been associated with congenital thrombocytopenia, radioulnar synostosis and bone marrow failure; however, the phenotypic spectrum of MECOM ‐associated syndromes continues to expand and novel pathogenic variants continue to be identified. We describe eight unrelated patients who add to the previously known phenotypes and genetic defects of MECOM ‐associated syndromes. As each subject presented with unique MECOM variants, the series failed to demonstrate clear genotype‐to‐phenotype correlation but may suggest a role for additional modifiers that affect gene expression and subsequent phenotype. Recognition of the expanded hematologic and non‐hematologic clinical features allows for rapid molecular diagnosis, early identification of life‐threatening complications, and improved genetic counseling for families. A centralized international publicly accessible database to share annotated MECOM variants would advance their clinical interpretation and provide a foundation to perform functional MECOM studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Primary Children's Hospital, University of Utah, Salt Lake City, Utah, USA.
- University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.
- Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.
- Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colorado, USA.
- Johns Hopkins Hospital, Baltimore, Maryland, USA.
- Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston Children's Hospital, Boston, Massachusetts, USA.
ORCID-Profile: Akiko Shimamura, Taizo A Nakano
Förderung
- NIDDK NIH HHS
- National Institutes of Health
Zitieren
APA
Lozano Chinga, M. M., Bertuch, A. A., Afify, Z., Dollerschell, K., Hsu, J. I., John, T. D., Rao, E. S., Rowe, R. G., Sankaran, V. G., Shimamura, A., Williams, D. A., & Nakano, T. A. (2023). Expanded phenotypic and hematologic abnormalities beyond bone marrow failure in MECOM ‐associated syndromes. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63208
Vancouver
Lozano Chinga MM, Bertuch AA, Afify Z, Dollerschell K, Hsu JI, John TD, et al. Expanded phenotypic and hematologic abnormalities beyond bone marrow failure in MECOM ‐associated syndromes. American Journal of Medical Genetics Part A. 2023. doi:10.1002/ajmg.a.63208
BibTeX
@article{LozanoChinga2023,
author = {Lozano Chinga, Michell M and Bertuch, Alison A and Afify, Zeinab and Dollerschell, Kaylee and Hsu, Joanne I and John, Tami D and Rao, Emily S and Rowe, Robert Grant and Sankaran, Vijay G and Shimamura, Akiko and Williams, David A and Nakano, Taizo A},
title = {Expanded phenotypic and hematologic abnormalities beyond bone marrow failure in MECOM ‐associated syndromes},
journal = {American Journal of Medical Genetics Part A},
year = {2023},
doi = {10.1002/ajmg.a.63208}
}
EUVIMED